| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 38,869 | 35,319 | 35,111 | 35,784 | | Cost of Revenue | 8,393 | 13,805 | 11,072 | 14,554 | | | Gross Profit | 30,476 | 21,514 | 24,039 | 21,230 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 7,710 | 6,942 | 6,141 | 4,674 | | Non Recurring |
-
|
-
|
-
| 4,392 | | Others | 10,352 | 8,468 | 8,592 | 12,765 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 12,414 | 6,104 | 9,306 | (601) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 15,252 | 3,895 | 3,150 | 1,958 | | Earnings Before Interest And Taxes | 8,578 | 10,048 | 9,149 | 5,742 | | Interest Expense | 8,330 | 7,631 | 7,821 | 6,435 | | Income Before Tax | 248 | 2,417 | 1,328 | (693) | | Income Tax Expense | (273) | 1,096 | 526 | 971 | | Minority Interest |
-
|
-
|
-
| 8,847 | | | | Net Income From Continuing Ops | 521 | 1,321 | 802 | (1,664) | | | Non-recurring Events | | Discontinued Operations | 47 |
-
| 5,815 | (2,429) | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 16,803 | 1,321 | 6,617 | (4,093) | | Preferred Stock And Other Adjustments | (9,496) | 5,814 | 3,682 |
-
| | | Net Income Applicable To Common Shares | $7,307 | $7,135 | $10,299 | ($4,093) |
|
0.51% Nasdaq 
Income Statement
